Oncology Journal Issues Research Articles in October 2022 Edition
October 21, 2022
October 21, 2022
CHICAGO, Illinois, Oct. 21 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its October 2022 edition:
Original Investigations:
* Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial
< . . .
Original Investigations:
* Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial
< . . .